A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Clinical trial NCT06712654 · RECRUITING

Trial details

NCT number: NCT06712654
Sponsor: R1 Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperphosphatemia Chronic Kidney Disease Requiring Chronic Dialysis End Stage Renal Disease on Dialysis

Start date: 2026-06-01
Primary completion: 2027-02-28
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.